Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Apr 15;70(16):1313-21.
doi: 10.1212/01.wnl.0000291011.54508.aa. Epub 2008 Mar 12.

Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome

Affiliations
Comparative Study

Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome

J L Neul et al. Neurology. .

Abstract

Objective: To determine if a relationship exists between the clinical features of Rett syndrome, an X-linked dominant neurodevelopmental disorder, and specific mutations in MECP2.

Method: Cross-sectional study of 245 girls and women with typical Rett syndrome seen between 1990 and 2004 in tertiary academic outpatient specialty clinics and who had complete MECP2 mutation analysis. A structured clinical evaluation was completed for each participant. The results were grouped by MECP2 mutation and compared.

Results: Participants with the R133C mutation are less severely affected than those with R168X or large DNA deletions (p < 0.05). Likewise, individuals with the R168X mutation are more severely affected than those with R294X and late carboxy-terminal truncating mutations (p < 0.05). Clinical differences are notable in ambulation, hand use, and language (p < 0.004), three cardinal features of Rett syndrome. Individuals with R168X are less likely to walk (p = 0.008), retain hand use (p = 0.002), or use words (p = 0.001). In contrast, those with carboxy-terminal truncations are more likely to walk (p = 0.007) and use words (p < 0.001). The R306C mutation, previously found to confer milder features, adversely affects only one clinical feature, language (p < 0.05).

Conclusions: Specific mutations in MECP2 confer different severity. These results allow the design of therapies targeted toward the amelioration of expected problems. Furthermore, the distinct effects of MECP2 mutations on clinical severity must be considered in clinical intervention trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Clinical severity depends on specific MECP2 mutations
There is an overall difference (p=0.0007) in the CSS between different mutations (listed along the x-axis). The asterisk (*) and the number sign (#) show significant (p<0.05) post-hoc pair-wise differences. Values represent mean ± SEM.
Figure 2
Figure 2. Dissociation of the clinical severity for individuals with R306C
The percentage of individuals with a given mutation (given along the x-axis) who are able to walk alone (grey), have some preserved hand use (black) or uses words (white) is shown along the y-axis.

Comment in

References

    1. Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, et al. Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 2006;148(3):347–352. - PubMed
    1. Neul JL, Zoghbi HY. Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist. 2004;10(2):118–128. - PubMed
    1. Glaze DG. Neurophysiology of Rett syndrome. J Child Neurol. 2005;20(9):740–746. - PubMed
    1. Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol. 2002;6(5):293–297. - PubMed
    1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23(2):185–188. - PubMed

Publication types

Substances